BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng H, Hou L, Zha P, Huang K, Peng L. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis. European Journal of Surgical Oncology 2019;45:728-35. [DOI: 10.1016/j.ejso.2018.09.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Shinohara S, Nakagawa M. ASO Author Reflections: The Significance of Limited Surgery Among Patients with Sarcopenia. Ann Surg Oncol 2020;27:2436-7. [PMID: 32112211 DOI: 10.1245/s10434-020-08287-y] [Reference Citation Analysis]
2 Aleixo GFP, Williams GR, Nyrop KA, Muss HB, Shachar SS. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review. Breast Cancer Res Treat 2019;177:569-79. [PMID: 31292800 DOI: 10.1007/s10549-019-05352-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
3 Nishimura JM, Ansari AZ, D’souza DM, Moffatt-bruce SD, Merritt RE, Kneuertz PJ. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery. The Annals of Thoracic Surgery 2019;108:1555-64. [DOI: 10.1016/j.athoracsur.2019.04.090] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
4 Albano D, Messina C, Vitale J, Sconfienza LM. Imaging of sarcopenia: old evidence and new insights. Eur Radiol 2020;30:2199-208. [DOI: 10.1007/s00330-019-06573-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
5 Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020;54:237-46. [PMID: 32229679 DOI: 10.2478/raon-2020-0016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Dong X, Dan X, Yawen A, Haibo X, Huan L, Mengqi T, Linglong C, Zhao R. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning. Thorac Cancer 2020;11:2650-9. [PMID: 32767522 DOI: 10.1111/1759-7714.13598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li S, Wang T, Tong G, Li X, You D, Cong M. Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:726257. [PMID: 34513704 DOI: 10.3389/fonc.2021.726257] [Reference Citation Analysis]
8 Katsui K, Ogata T, Watanabe K, Yoshio K, Kuroda M, Yamane M, Hiraki T, Kiura K, Toyooka S, Kanazawa S. Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer. Int J Clin Oncol 2021;26:1450-60. [PMID: 33880655 DOI: 10.1007/s10147-021-01927-7] [Reference Citation Analysis]
9 Dolan DP, White A, Mazzola E, Lee DN, Gill R, Kucukak S, Bueno R, Jaklitsch MT, Mentzer SJ, Swanson SJ. Outcomes of superior segmentectomy versus lower lobectomy for superior segment Stage I non-small-cell lung cancer are equivalent: An analysis of 196 patients at a single, high volume institution. J Surg Oncol 2021;123:570-8. [PMID: 33259656 DOI: 10.1002/jso.26304] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Deng HY, Chen ZJ, Qiu XM, Zhu DX, Tang XJ, Zhou Q. Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis. Nutrition 2021;90:111345. [PMID: 34166897 DOI: 10.1016/j.nut.2021.111345] [Reference Citation Analysis]
11 Koh FH, Chua JM, Tan JL, Foo FJ, Tan WJ, Sivarajah SS, Ho LML, Teh BT, Chew MH. Paradigm shift in gastrointestinal surgery − combating sarcopenia with prehabilitation: Multimodal review of clinical and scientific data. World J Gastrointest Surg 2021; 13(8): 734-755 [PMID: 34512898 DOI: 10.4240/wjgs.v13.i8.734] [Reference Citation Analysis]
12 Surov A, Pech M, Gessner D, Mikusko M, Fischer T, Alter M, Wienke A. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis. Clin Nutr 2021;40:5298-310. [PMID: 34536638 DOI: 10.1016/j.clnu.2021.08.023] [Reference Citation Analysis]
13 Nagata M, Ito H, Yokose T, Tokushige A, Ueda S, Nakayama H. Effect of progressive sarcopenia during postoperative 6 months on long-term prognosis of completely resected lung cancer. J Thorac Dis 2019;11:3411-20. [PMID: 31559045 DOI: 10.21037/jtd.2019.08.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Possner M, Alsaied T, Siddiqui S, Morales D, Trout AT, Veldtman G. Abdominal Skeletal Muscle Index as a Potential Novel Biomarker in Adult Fontan Patients. CJC Open 2020;2:55-61. [PMID: 32190826 DOI: 10.1016/j.cjco.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Katsui K, Ogata T, Sugiyama S, Yoshio K, Kuroda M, Hiraki T, Kiura K, Maeda Y, Toyooka S, Kanazawa S. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis. Sci Rep 2021;11:11882. [PMID: 34088965 DOI: 10.1038/s41598-021-91449-z] [Reference Citation Analysis]
16 Surov A, Wienke A. Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis. Ther Adv Med Oncol 2021;13:17588359211008844. [PMID: 34035838 DOI: 10.1177/17588359211008844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Barnard R, Tan J, Roller B, Chiles C, Weaver AA, Boutin RD, Kritchevsky SB, Lenchik L. Machine Learning for Automatic Paraspinous Muscle Area and Attenuation Measures on Low-Dose Chest CT Scans. Acad Radiol 2019;26:1686-94. [PMID: 31326311 DOI: 10.1016/j.acra.2019.06.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
18 Shoji F. Clinical impact of preoperative immunonutritional status in patients undergoing surgical resection of lung cancer. J Thorac Dis 2019;11:S408-12. [PMID: 30997233 DOI: 10.21037/jtd.2018.11.118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Kidd AC, Skrzypski M, Jamal-hanjani M, Blyth KG. Cancer cachexia in thoracic malignancy: a narrative review. Current Opinion in Supportive & Palliative Care 2019;13:316-22. [DOI: 10.1097/spc.0000000000000465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Li J, Deng Y, Zhang M, Cheng Y, Zhao X, Ji Z. Prognostic value of radiologically determined sarcopenia prior to treatment in urologic tumors: A meta-analysis. Medicine (Baltimore) 2019;98:e17213. [PMID: 31567976 DOI: 10.1097/MD.0000000000017213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ilic I, Faron A, Heimann M, Potthoff AL, Schäfer N, Bode C, Borger V, Eichhorn L, Giordano FA, Güresir E, Jacobs AH, Ko YD, Landsberg J, Lehmann F, Radbruch A, Herrlinger U, Vatter H, Schuss P, Schneider M. Combined Assessment of Preoperative Frailty and Sarcopenia Allows the Prediction of Overall Survival in Patients with Lung Cancer (NSCLC) and Surgically Treated Brain Metastasis. Cancers (Basel) 2021;13:3353. [PMID: 34283079 DOI: 10.3390/cancers13133353] [Reference Citation Analysis]
22 Kawaguchi Y, Hanaoka J, Ohshio Y, Okamoto K, Kaku R, Hayashi K, Shiratori T, Akazawa A. Does sarcopenia affect postoperative short- and long-term outcomes in patients with lung cancer?-a systematic review and meta-analysis. J Thorac Dis 2021;13:1358-69. [PMID: 33841929 DOI: 10.21037/jtd-20-3072] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Rozynek M, Kucybała I, Urbanik A, Wojciechowski W. Use of artificial intelligence in the imaging of sarcopenia: A narrative review of current status and perspectives. Nutrition 2021;89:111227. [PMID: 33930789 DOI: 10.1016/j.nut.2021.111227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yun NK, Rouhani SJ, Bestvina CM, Ritz EM, Gilmore BA, Tarhoni I, Borgia JA, Batus M, Bonomi PD, Fidler MJ. Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers (Basel) 2021;13:1426. [PMID: 33804721 DOI: 10.3390/cancers13061426] [Reference Citation Analysis]
25 Dolan D, Swanson SJ, Gill R, Lee DN, Mazzola E, Kucukak S, Polhemus E, Bueno R, White A. Survival and Recurrence Following Wedge Resection Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer. Semin Thorac Cardiovasc Surg 2021:S1043-0679(21)00269-0. [PMID: 34098122 DOI: 10.1053/j.semtcvs.2021.04.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nagata M, Ito H, Yoshida T, Tokushige A, Ueda S, Yokose T, Nakayama H. Risk factors for progressive sarcopenia 6 months after complete resection of lung cancer: what can thoracic surgeons do against sarcopenia? J Thorac Dis 2020;12:307-18. [PMID: 32274097 DOI: 10.21037/jtd.2020.01.44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Kim EY, Kim YJ, Kim YS, Kim KW, Jeon JY, Kim KG. Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer. J Thorac Dis 2021;13:754-61. [PMID: 33717547 DOI: 10.21037/jtd-20-2344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhang XM, Dou QL, Zeng Y, Yang Y, Cheng ASK, Zhang WW. Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review. BMC Cancer. 2020;20:172. [PMID: 32131764 DOI: 10.1186/s12885-020-6645-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
29 Tagliafico AS, Bignotti B, Torri L, Rossi F. Sarcopenia: how to measure, when and why. Radiol Med 2022. [PMID: 35041137 DOI: 10.1007/s11547-022-01450-3] [Reference Citation Analysis]
30 Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X. Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med 2020;9:7964-78. [PMID: 32924316 DOI: 10.1002/cam4.3428] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
31 Shinohara S, Otsuki R, Kobayashi K, Sugaya M, Matsuo M, Nakagawa M. Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer. Ann Surg Oncol 2020;27:2427-35. [PMID: 31970570 DOI: 10.1245/s10434-020-08224-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
32 Tagliafico AS, Rossi F, Bignotti B, Torri L, Bonsignore A, Belgioia L, Domineitto A. CT-derived relationship between low relative muscle mass and bone damage in patients with multiple myeloma undergoing stem cells transplantation. Br J Radiol 2021;:20210923. [PMID: 34918544 DOI: 10.1259/bjr.20210923] [Reference Citation Analysis]
33 Yang M, Tan L, Xie L, Hu S, Liu D, Wang J, Li W. Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer. Front Oncol 2021;11:754975. [PMID: 34660324 DOI: 10.3389/fonc.2021.754975] [Reference Citation Analysis]
34 Köstek O, Demircan NC, Gökyer A, Küçükarda A, Sunal BS, Hacıoğlu MB, Eslame H, Solak S, Yılmaz E, Uzunoğlu S, Tunçbilek N, Çiçin I, Erdoğan B. Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer. Clin Transl Oncol 2019;21:1510-7. [PMID: 30924091 DOI: 10.1007/s12094-019-02079-x] [Reference Citation Analysis]
35 Matsuo Y. Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer. J Thorac Dis 2019;11:S443-5. [PMID: 30997243 DOI: 10.21037/jtd.2018.11.44] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Burtin C, Bezuidenhout J, Sanders KJC, Dingemans AC, Schols AMWJ, Peeters STH, Spruit MA, De Ruysscher DKM. Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy. J Cachexia Sarcopenia Muscle 2020;11:424-31. [PMID: 32045108 DOI: 10.1002/jcsm.12526] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
37 Phillips I, Kestenbaum S. Optimising patient fitness: strategies to reduce the effects of cancer cachexia in patients with advanced lung cancer. Curr Opin Support Palliat Care 2020;14:304-8. [PMID: 33181607 DOI: 10.1097/SPC.0000000000000525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Wang J, Cao L, Xu S. Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis. International Immunopharmacology 2020;88:106907. [DOI: 10.1016/j.intimp.2020.106907] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
39 Deng HY, Jiang R. It is time to consider incorporating sarcopenia assessment in the surgical management of non-small-cell lung cancer. Gen Thorac Cardiovasc Surg 2019;67:653-4. [PMID: 31134528 DOI: 10.1007/s11748-019-01144-0] [Reference Citation Analysis]
40 Ferguson MK, Mitzman B, Derstine B, Lee SM, Pienta MJ, Wang SC, Lin J. A Morphomic Index Is an Independent Predictor of Survival After Lung Cancer Resection. Ann Thorac Surg 2020;109:873-8. [PMID: 31862495 DOI: 10.1016/j.athoracsur.2019.10.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Takahashi Y, Suzuki S, Hamada K, Nakada T, Oya Y, Sakakura N, Matsushita H, Kuroda H. Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer. Ann Transl Med 2021;9:325. [PMID: 33708952 DOI: 10.21037/atm-20-4380] [Reference Citation Analysis]